Neurology

Nerve regeneration with polyhydroxyalkanoate-based conduits 2:26
Nerve regeneration with polyhydroxyalkanoate-based conduits
Ipsita Roy • 11 Nov 2021
Researching the impact of innervation on regenerating tissues 1:28
Researching the impact of innervation on regenerating tissues
Paul Wieringa • 18 Nov 2021
Research barriers in neural engineering 2:03
Research barriers in neural engineering
Paul Wieringa • 18 Nov 2021
The role of stem cells in treating CNS disorders 4:07
The role of stem cells in treating CNS disorders
Anne des Rieux • 25 Nov 2021
Delivering drugs to the CNS with extracellular vesicles 1:58
Delivering drugs to the CNS with extracellular vesicles
Anne des Rieux • 25 Nov 2021
Neural stem cells isolated from the CSF for a potential autologous cell therapy 4:49
Neural stem cells isolated from the CSF for a potential autologous cell therapy
Beatriz Fernández-Muñoz • 25 Jun 2021
Challenges with translating gene therapies for neurodevelopmental disorders 2:44
Challenges with translating gene therapies for neurodevelopmental disorders
Ralf Schmid • 16 Nov 2021
Non-viral gene delivery & gene editing: highlights from ESGCT 2:56
Non-viral gene delivery & gene editing: highlights from ESGCT
Ralf Schmid • 16 Nov 2021
Eladocagene exuparvovec: AAV2-mediated gene therapy for AADC deficiency 8:51
Eladocagene exuparvovec: AAV2-mediated gene therapy for AADC deficiency
Paul Wuh-Liang Hwu • 17 Nov 2021
LYS-GM101 AAV gene therapy for GM1 gangliosidosis 6:19
LYS-GM101 AAV gene therapy for GM1 gangliosidosis
Michael Hocquemiller • 15 Nov 2021
The gene-replacement therapy landscape for CDKL5-deficiency disorder 3:49
The gene-replacement therapy landscape for CDKL5-deficiency disorder
Ralf Schmid • 16 Nov 2021
AAV9-mediated gene therapy for CDKL5-deficiency disorder 4:23
AAV9-mediated gene therapy for CDKL5-deficiency disorder
Ralf Schmid • 16 Nov 2021
LYS-SAF302 AAV gene therapy for MPS IIIA 2:38
LYS-SAF302 AAV gene therapy for MPS IIIA
Michael Hocquemiller • 15 Nov 2021
ESGCT 2021 highlights: AAV vector capsid modification for CNS disorders 1:48
ESGCT 2021 highlights: AAV vector capsid modification for CNS disorders
Michael Hocquemiller • 15 Nov 2021
Applications of brain organoids in neurology 1:14
Applications of brain organoids in neurology
Ira Espuny-Camacho • 9 Nov 2021
ATA3219, ATA3271 & ATA188: T-Cell immunotherapy products in development 3:59
ATA3219, ATA3271 & ATA188: T-Cell immunotherapy products in development
Pascal Touchon • 22 Oct 2021
The content of VJRegenMed is intended for healthcare professionals